|
Update on Bisphosphonates FDA-Approved for Prevention and Treatment of Osteoporosis
- Original Release Date: July, 2008
- Expiration Date: July, 2010
- Estimated Time to Complete this Education Activity: 1.0 hours
- Type of Enduring Material: Internet-Based CE
- Method of Physician Participation in the learning process: Physician learners will read and analyze the subject matter, conduct additional informal research through related internet searches on the subject matter, and complete a post-test assessment of knowledge and skills gained as a result of the activity.
Learning Objectives
Upon completion of this CE activity, the participant should be able to:
- Describe the action of bisphosphonate drugs on bone
- Compare the effectiveness of various FDA-approved bisphosphonates available for prevention and treatment of osteoporosis
- Cite the circumstances under which it is appropriate to consider a “drug holiday” from bisphosphonate treatment
- Discuss potential osteoporosis treatment plans tailored to fit particular patient profiles
- Explain the criteria for assessing patient response to bisphosphonate treatment
Click here to access Update on Bisphosphonates FDA-Approved for Prevention and Treatment of Osteoporosis.
If you wish to receive continuing education credit, please click here and complete the registration form. After completing the form, you will go directly to the 5-question post- test, test scoring, and course evaluation. You must complete the post-test and evaluation in order to receive credit. It will take approximately ½ hour to complete the test, test scoring, and evaluation.
Once you submit your registration, you must complete the test and evaluation in one session. You cannot leave the website and return to the test or evaluation.
There is a $10.00 fee for this continuing education activity. Payment may be made by VISA, MasterCard, or American Express. We cannot accept any other forms of payment. Please complete the payment form found after you complete the evaluation.
ACCREDITATION INFORMATION
The National Osteoporosis Foundation is accredited by the Accreditation Council for Continuing Education to provide continuing education for physicians. The National Osteoporosis Foundation designates this educational activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Software Requirement:
Adobe Acrobat Reader is required to read
the text for this continuing education
activity.
If you do not have Adobe Acrobat Reader, click here.
|
